(i) Radioprotective phytochemicals |
Curcumin |
50 µg/mL |
1.5 Gy |
Curcumin-encapsulated bioglass-chitosan might have promising potential applications for wound healing resulting from gamma radiation. |
[127] |
Sesamol |
10 μg/mL |
4 Gy |
(i) Renders protection on γ-radiation induced DNA damage, and antioxidants depletion in cultured human lymphocytes. |
[128,129] |
100 mg/kg |
7.5 Gy |
(ii) Acts as a single prophylactic dose protects hematopoietic and GI systems against γ-radiation-induced injury in mice. |
Ferulic acid |
10 μg/mL |
4 Gy |
Prevents γ-radiation-induced micronuclei and dicentric aberration in human lymphocytes. |
[130,131] |
50 mg/kg |
4 Gy |
Enhances the survival of mice possibly by decreasing DNA damage as examined by γH2AX foci, micronuclei formation, and comet assay. |
Apigenin |
10 μg/mL |
3 Gy |
Significantly reduced (p < 0.01) the frequency of mitomycin C-induced micronuclei. |
[132] |
Mangiferin |
5–25 μg/mL |
5 Gy |
Protects against gamma radiation-induced DNA damage and acts as an antioxidant or pro-oxidant product |
[133] |
Naringin |
50 and 100 µM |
6 Gy |
Prevents radiation-induced multiple cellular anomalies. |
[134] |
Paeoniflorin |
200 μg/mL |
4 Gy |
Offers protection against radiation-induced cell damage through modulation of reactive oxygen species and the mitogen-activated protein kinases in thymocytes. |
[135] |
50–200 µg/mL |
10 Gy |
Protected EA.hy926 cells against radiation-induced injury through the Nrf2/HO-1 pathway. |
[136] |
Luteolin |
10 μmol/kg b.wt. |
6 Gy |
Radioprotective effects through antioxidative property in mice. |
[137] |
Lignans from Myristica fragrans |
500 µg/mL |
4.26 Gy |
Radioprotection through immunomodulation in mammalian splenocytes. |
[138] |
Hesperidin |
50–100 mg/kg b.wt. |
5 Gy |
Protects against γ-radiation-induced cellular damage and oxidative stress in rats. |
[139] |
α-tocopherol |
360 mg/kg b.wt. |
15 Gy |
Radioprotective effect of Vitamin E in Parotid Glands in rats. |
[140] |
Catechines |
100 μM |
3 Gy |
Protects pBR322 DNA under acellular conditions and normal splenocytes under cellular conditions, against γ-radiation-induced damage. |
[141] |
Orientin |
17.5 μM |
4 Gy |
Promotes stem cell survival, exogenous spleen colony formation (CFU-S). |
[142] |
Silymarin |
50 mg/kg |
3 Gy |
Protects experimental animals from radiation-induced hepatotoxicity. |
[143] |
Zingerone |
10 μg/mL |
2 Gy |
Prevents radiation-induced genetic damage and apoptosis in human lymphocytes. |
[144] |
Rutin |
10 mg/kg b.wt. |
3 Gy |
Mitigates radiation-induced mortality and cytogenetic damage, which attributes to scavenging of radiation-induced free radicals. |
[145] |
Lycopene |
5 mg/kg b.wt. |
6 Gy |
Protects the small intestine against radiation-induced damage. |
[146] |
Glycyrrhizic acid |
4 mM |
1.25 Gy |
Offers protection against γ-radiation-induced DNA damage to plasmid pBR322 in vitro, human peripheral blood leukocytes and bone marrow cells in vivo. |
[147] |
Naringin |
7.5 mg/kg b.wt. |
1–5 Gy |
Protects mouse bone marrow cells against radiation-induced chromosomal aberrations and lipid peroxidation. |
[148] |
Quercetin |
2–50 μM |
30 Gy |
Protects against radiation- and storage-induced oxidative damage to RBCs. |
[149] |
Morin |
25 μM |
10 Gy |
Protects against oxidative stress induced by radiation via reduction of ROS and attenuation of the SEK1-JNK-AP-1 pathway. |
[150] |
Dehydrozingerone |
100 mg/kg b.wt. |
10 Gy |
Exhibits radioprotective activity in whole body gamma irradiated Swiss albino mice through free radical scavenging. The DMF value was found to be 1.09. |
[151] |
Famotidine |
200 µg/mL |
4–12 Gy |
Suppresses radiation-induced apoptosis with various doses of gamma-irradiation via radical scavenging and intracellular antioxidation mechanism. |
[152] |
Pilocarpine |
4 mg/kg b.wt. |
15 Gy |
Amelioration of long term radiation-induced hyposalivation using prophylactic pilocarpine treatment |
[153] |
Podophyllotoxin |
10 nM |
10 Gy |
Derivatives are used in combination with IR therapy and suggest that the EGFR–p38/ERK–STAT3/CREB-1–EMT pathway might be a useful target for suppressing metastasis. |
[154] |
(ii) Radiosensitizing phytochemicals |
Hypericin |
5 µM |
8 Gy |
Enhancement of radiosensitivity in human malignant glioma cells. |
[155] |
Epigallocatechin-galate |
25 mg/kg b.wt. |
22 Gy |
Inhibits irradiation-induced pulmonary fibrosis. |
[156] |
Resveratrol |
1 mg/mL |
70 kGy |
Reduces toxicity and plays a potent role in the treatment of inflammatory disease. |
[157] |
Curcumin |
100 μM |
10 Gy |
Acts as radiosensitizer through prooxidant mechanisms in cancer cells. |
[158] |
Gossypol |
2 μM |
6 Gy |
Radiosensitization of tumour cell lines by depressig double-strand break repair mechanism. |
[159] |
Betulinic acid |
20 μM |
2 Gy |
Induces cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions. |
[160] |
Plumbagin |
750 nM |
2 Gy |
Radiosensitizing effects in cervical cancer cells through modulation of apoptotic pathway. |
[161] |
Withaferin A |
4 μM |
10 Gy |
Enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. |
[162] |
Ellagic acid |
100 μmol/L |
6 Gy |
Enhances radiation-induced oxidative stress and subsequent cytotoxicity in tumor cells. |
[163] |
Caffeic acid |
10μmol/kgb.wt. |
7 Gy |
Exhibits curable effects on gamma irradiation-induced cardiac-oxidative impairment in rats. |
[164] |
Genistein |
20 μM |
5 Gy |
Acts as a prooxidant in HL-60 cells, increases ionizing radiation-induced cell cycle arrest and sensitivity to apoptotic cell death in human promyeloid leukemia HL-60 cells. |
[165] |
Myricetin |
25 µM |
2 Gy |
Enhances radiosensitivity of lung cancer A549 and H1299 cells. |
[114] |
Biochanin A |
1–100 µM |
2 Gy |
Enhances radiotoxicity in colon tumor cells. |
[166] |
Capsaicin |
1–10 µM |
1–8 Gy |
Increases radiation effects in prostate cancer. |
[167] |
Piperine |
40 μM |
15 Gy |
Enhances radiosensitivity of tumor cells through oxidative mechanism. |
[168] |
Lupeol |
30 μmol/L |
4 Gy |
Enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo.
|
[169] |
Oleanolic acid |
35 µg/mL |
250 Gy/min |
Radiosensitizes tumor cells through the inhibition of GSH synthesis in vitro. |
[170] |